(Q43554142)

24 November 2017

title

Effect of VIP on the balance between cytokines and master regulators of activated helper T cells (English)

1 reference

24 November 2017

author

Irene Gutiérrez-Cañas

object named as

Irene Gutiérrez-Cañas

4

0 references

author name string

Rebeca Jimeno

1

1 reference

24 November 2017

Javier Leceta

2

1 reference

24 November 2017

Carmen Martínez

3

1 reference

24 November 2017

Selene Pérez-García

5

1 reference

24 November 2017

Mar Carrión

6

1 reference

24 November 2017

Rosa P Gomariz

7

1 reference

24 November 2017

Yasmina Juarranz

8

1 reference

24 November 2017

publication date

29 March 2011

1 reference

Immunology & Cell Biology

24 November 2017

published in

1 reference

24 November 2017

volume

90

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

178-186

1 reference

Induction and effector functions of T(H)17 cells.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Effector T cell plasticity: flexibility in the face of changing circumstances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Multi-tasking of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

CD4 T cells: fates, functions, and faults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Heterogeneity and plasticity of T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

VPAC and PAC receptors: From ligands to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Immunology of VIP: a review and therapeutical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

VIP-PACAP system in immunity: new insights for multitarget therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Vasoactive intestinal peptide as a healing mediator in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Differentiation of effector CD4 T cell populations (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Cellular and molecular basis for the regulation of inflammation by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Immune suppressive activity and lack of T helper differentiation are differentially regulated in natural regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Effects of vasoactive intestinal peptide on phenotypic and functional maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Control of regulatory T cell lineage commitment and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

Effect of calcitonin gene-related peptide and vasoactive intestinal peptide on murine CD4 and CD8 T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.23

7 January 2021

Identifiers

DOI

10.1038/ICB.2011.23

1 reference

24 November 2017

1 reference